Trials / Conditions / Vulvar HSIL
Vulvar HSIL
3 registered clinical trials studyying Vulvar HSIL — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions NCT06075264 | Frantz Viral Therapeutics, LLC | Phase 2 |
| Not Yet Recruiting | Adjuvant Nonavalent HPV Vaccination in Women Treated for Vulvar HSIL NCT06052696 | Erasmus Medical Center | Phase 4 |
| Terminated | Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions NCT03937791 | National Cancer Institute (NCI) | Phase 2 |